Yoichi Naito

38PUBLICATIONS
174CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpidemiological methodsPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jul 01, 2026
De-escalation of breast surgery for early stage breast cancer.

|Mar 26, 2026
Sacituzumab govitecan in Japanese participants with HR+/HER2- metastatic breast cancer: primary results from the phase II ASCENT-J02 study.

Akihiko Shimomura, Takahiro Kogawa, Koji Matsumoto

|Jan 30, 2026
A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110).

Keita Sasaki, Toshiyuki Ishiba, Ikuno Nishibuchi

|Jul 17, 2025
Epidemiologic Features and Age-Related Differences in Management among Patients with Gastrointestinal Stromal Tumors in Japan: A National Cancer Registry Study.

Hidekazu Hirano, Yoichi Naito, Toshirou Nishida

|Apr 27, 2025
A subgroup analysis of the MiroCIP study to evaluate chemotherapy-induced peripheral neuropathy: symptom profile, severity, and analgesia efficacy depending on type of chemotherapy.

Sonoko Misawa, Takahiro Kogawa, Yoichi Naito

|Apr 17, 2025
First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer.

Timothy A Yap, Jonathan W Goldman, Shaveta Vinayak

Pageof 7

Frequent Collaborators

7 joint publications

Nobuaki Matsubara

6 joint publications

Hideaki Bando

4 joint publications

Akihiko Shimomura

4 joint publications

Toru Mukohara